nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—saliva—acquired immunodeficiency syndrome	0.014	0.0725	CbGeAlD
Mesalazine—Olsalazine—IFNG—acquired immunodeficiency syndrome	0.00716	0.794	CrCbGaD
Mesalazine—MPO—endothelium—acquired immunodeficiency syndrome	0.00688	0.0355	CbGeAlD
Mesalazine—CHUK—skin of body—acquired immunodeficiency syndrome	0.00617	0.0318	CbGeAlD
Mesalazine—MPO—blood plasma—acquired immunodeficiency syndrome	0.00611	0.0316	CbGeAlD
Mesalazine—PPARG—endothelium—acquired immunodeficiency syndrome	0.00611	0.0315	CbGeAlD
Mesalazine—PPARG—blood plasma—acquired immunodeficiency syndrome	0.00542	0.028	CbGeAlD
Mesalazine—CHUK—lymphoid tissue—acquired immunodeficiency syndrome	0.00499	0.0258	CbGeAlD
Mesalazine—CHUK—digestive system—acquired immunodeficiency syndrome	0.00493	0.0255	CbGeAlD
Mesalazine—CHUK—blood—acquired immunodeficiency syndrome	0.0047	0.0242	CbGeAlD
Mesalazine—IKBKB—skin of body—acquired immunodeficiency syndrome	0.00419	0.0216	CbGeAlD
Mesalazine—CHUK—lung—acquired immunodeficiency syndrome	0.00412	0.0213	CbGeAlD
Mesalazine—IKBKB—lymphoid tissue—acquired immunodeficiency syndrome	0.00339	0.0175	CbGeAlD
Mesalazine—IKBKB—digestive system—acquired immunodeficiency syndrome	0.00335	0.0173	CbGeAlD
Mesalazine—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00327	0.0169	CbGeAlD
Mesalazine—IKBKB—blood—acquired immunodeficiency syndrome	0.00319	0.0165	CbGeAlD
Mesalazine—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00312	0.0161	CbGeAlD
Mesalazine—IKBKB—vagina—acquired immunodeficiency syndrome	0.00296	0.0153	CbGeAlD
Mesalazine—MPO—skin of body—acquired immunodeficiency syndrome	0.00294	0.0152	CbGeAlD
Mesalazine—CHUK—brain—acquired immunodeficiency syndrome	0.00292	0.015	CbGeAlD
Mesalazine—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.0029	0.015	CbGeAlD
Mesalazine—CHUK—lymph node—acquired immunodeficiency syndrome	0.00282	0.0145	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—acquired immunodeficiency syndrome	0.00281	0.0145	CbGeAlD
Mesalazine—IKBKB—lung—acquired immunodeficiency syndrome	0.0028	0.0145	CbGeAlD
Mesalazine—ALOX5—digestive system—acquired immunodeficiency syndrome	0.00278	0.0143	CbGeAlD
Mesalazine—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00277	0.0143	CbGeAlD
Mesalazine—ALOX5—blood—acquired immunodeficiency syndrome	0.00265	0.0137	CbGeAlD
Mesalazine—PPARG—skin of body—acquired immunodeficiency syndrome	0.00261	0.0135	CbGeAlD
Mesalazine—IKBKB—nervous system—acquired immunodeficiency syndrome	0.00259	0.0134	CbGeAlD
Mesalazine—ALOX5—bone marrow—acquired immunodeficiency syndrome	0.00256	0.0132	CbGeAlD
Mesalazine—IKBKB—central nervous system—acquired immunodeficiency syndrome	0.0025	0.0129	CbGeAlD
Mesalazine—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00238	0.0123	CbGeAlD
Mesalazine—MPO—digestive system—acquired immunodeficiency syndrome	0.00235	0.0121	CbGeAlD
Mesalazine—ALOX5—lung—acquired immunodeficiency syndrome	0.00232	0.012	CbGeAlD
Mesalazine—MPO—blood—acquired immunodeficiency syndrome	0.00224	0.0116	CbGeAlD
Mesalazine—MPO—bone marrow—acquired immunodeficiency syndrome	0.00217	0.0112	CbGeAlD
Mesalazine—MPO—spinal cord—acquired immunodeficiency syndrome	0.00216	0.0111	CbGeAlD
Mesalazine—ALOX5—nervous system—acquired immunodeficiency syndrome	0.00215	0.0111	CbGeAlD
Mesalazine—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.00211	0.0109	CbGeAlD
Mesalazine—PPARG—digestive system—acquired immunodeficiency syndrome	0.00209	0.0108	CbGeAlD
Mesalazine—ALOX5—central nervous system—acquired immunodeficiency syndrome	0.00207	0.0107	CbGeAlD
Mesalazine—PPARG—blood—acquired immunodeficiency syndrome	0.00199	0.0103	CbGeAlD
Mesalazine—IKBKB—brain—acquired immunodeficiency syndrome	0.00198	0.0102	CbGeAlD
Mesalazine—MPO—lung—acquired immunodeficiency syndrome	0.00196	0.0101	CbGeAlD
Mesalazine—PPARG—bone marrow—acquired immunodeficiency syndrome	0.00192	0.00993	CbGeAlD
Mesalazine—IKBKB—lymph node—acquired immunodeficiency syndrome	0.00191	0.00988	CbGeAlD
Mesalazine—PPARG—vagina—acquired immunodeficiency syndrome	0.00184	0.00951	CbGeAlD
Mesalazine—MPO—nervous system—acquired immunodeficiency syndrome	0.00182	0.00938	CbGeAlD
Mesalazine—MPO—central nervous system—acquired immunodeficiency syndrome	0.00175	0.00903	CbGeAlD
Mesalazine—PPARG—lung—acquired immunodeficiency syndrome	0.00174	0.00899	CbGeAlD
Mesalazine—ALOX5—brain—acquired immunodeficiency syndrome	0.00164	0.00848	CbGeAlD
Mesalazine—PPARG—nervous system—acquired immunodeficiency syndrome	0.00161	0.00833	CbGeAlD
Mesalazine—ALOX5—lymph node—acquired immunodeficiency syndrome	0.00159	0.00819	CbGeAlD
Mesalazine—PPARG—central nervous system—acquired immunodeficiency syndrome	0.00155	0.00802	CbGeAlD
Mesalazine—PTGS1—skin of body—acquired immunodeficiency syndrome	0.00139	0.0072	CbGeAlD
Mesalazine—MPO—brain—acquired immunodeficiency syndrome	0.00139	0.00717	CbGeAlD
Mesalazine—MPO—lymph node—acquired immunodeficiency syndrome	0.00134	0.00693	CbGeAlD
Mesalazine—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00133	0.00688	CbGeAlD
Mesalazine—PPARG—brain—acquired immunodeficiency syndrome	0.00123	0.00636	CbGeAlD
Mesalazine—Diflunisal—ALB—acquired immunodeficiency syndrome	0.00119	0.132	CrCbGaD
Mesalazine—PPARG—lymph node—acquired immunodeficiency syndrome	0.00119	0.00615	CbGeAlD
Mesalazine—PTGS1—digestive system—acquired immunodeficiency syndrome	0.00112	0.00576	CbGeAlD
Mesalazine—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00108	0.00557	CbGeAlD
Mesalazine—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00107	0.0055	CbGeAlD
Mesalazine—PTGS1—blood—acquired immunodeficiency syndrome	0.00106	0.00548	CbGeAlD
Mesalazine—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.00102	0.00528	CbGeAlD
Mesalazine—PTGS2—blood—acquired immunodeficiency syndrome	0.00102	0.00524	CbGeAlD
Mesalazine—PTGS1—vagina—acquired immunodeficiency syndrome	0.000985	0.00508	CbGeAlD
Mesalazine—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000983	0.00507	CbGeAlD
Mesalazine—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000978	0.00505	CbGeAlD
Mesalazine—PTGS2—vagina—acquired immunodeficiency syndrome	0.000941	0.00486	CbGeAlD
Mesalazine—PTGS1—lung—acquired immunodeficiency syndrome	0.000931	0.00481	CbGeAlD
Mesalazine—PTGS2—lung—acquired immunodeficiency syndrome	0.00089	0.00459	CbGeAlD
Mesalazine—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000862	0.00445	CbGeAlD
Mesalazine—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.00083	0.00429	CbGeAlD
Mesalazine—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000824	0.00426	CbGeAlD
Mesalazine—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000794	0.0041	CbGeAlD
Mesalazine—Salicylic acid—ALB—acquired immunodeficiency syndrome	0.000664	0.0736	CrCbGaD
Mesalazine—PTGS1—brain—acquired immunodeficiency syndrome	0.000659	0.0034	CbGeAlD
Mesalazine—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000637	0.00329	CbGeAlD
Mesalazine—PTGS2—brain—acquired immunodeficiency syndrome	0.00063	0.00325	CbGeAlD
Mesalazine—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000609	0.00314	CbGeAlD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000607	0.00485	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000606	0.00484	CbGpPWpGaD
Mesalazine—MPO—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000601	0.0048	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.000591	0.00472	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.000587	0.00469	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000582	0.00465	CbGpPWpGaD
Mesalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—acquired immunodeficiency syndrome	0.000578	0.00462	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000561	0.00448	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000558	0.00446	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000551	0.00441	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling—CD4—acquired immunodeficiency syndrome	0.000542	0.00433	CbGpPWpGaD
Mesalazine—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000542	0.00433	CbGpPWpGaD
Mesalazine—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000533	0.00426	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000528	0.00422	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	0.000522	0.00417	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000521	0.00417	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000496	0.00396	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—acquired immunodeficiency syndrome	0.000496	0.00396	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling—CD4—acquired immunodeficiency syndrome	0.000492	0.00393	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000489	0.00391	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000483	0.00386	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000481	0.00385	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000477	0.00381	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000456	0.00364	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000454	0.00363	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.00045	0.0036	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—acquired immunodeficiency syndrome	0.000449	0.00359	CbGpPWpGaD
Mesalazine—CHUK—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000443	0.00354	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000442	0.00353	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—TAT—acquired immunodeficiency syndrome	0.000441	0.00353	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000438	0.0035	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000432	0.00346	CbGpPWpGaD
Mesalazine—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.00043	0.00344	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000408	0.00326	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000405	0.00323	CbGpPWpGaD
Mesalazine—IKBKB—TNF receptor signaling pathway —TNF—acquired immunodeficiency syndrome	0.000402	0.00321	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000388	0.0031	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000387	0.00309	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000385	0.00308	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000384	0.00307	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.00038	0.00303	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000377	0.00301	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000375	0.003	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000366	0.00293	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000365	0.00292	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000351	0.0028	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000349	0.00279	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000349	0.00279	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000347	0.00277	CbGpPWpGaD
Mesalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	0.000338	0.0027	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000337	0.0027	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000335	0.00268	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000333	0.00267	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000316	0.00253	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000315	0.00252	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—acquired immunodeficiency syndrome	0.000313	0.0025	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.000308	0.00246	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000304	0.00243	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000304	0.00243	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00029	0.00232	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.000279	0.00223	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000276	0.0022	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000274	0.00219	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TNF—acquired immunodeficiency syndrome	0.000274	0.00219	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—TAT—acquired immunodeficiency syndrome	0.000273	0.00218	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000272	0.00217	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000265	0.00212	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000263	0.0021	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000261	0.00209	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000255	0.00204	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.00025	0.002	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TNF—acquired immunodeficiency syndrome	0.000248	0.00199	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000248	0.00199	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000246	0.00197	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000246	0.00196	CbGpPWpGaD
Mesalazine—CHUK—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000245	0.00196	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000242	0.00194	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	0.000242	0.00193	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000242	0.00193	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00024	0.00192	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000239	0.00191	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000237	0.00189	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000234	0.00187	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000232	0.00186	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000231	0.00185	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—acquired immunodeficiency syndrome	0.000219	0.00175	CbGpPWpGaD
Mesalazine—CHUK—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	0.000219	0.00175	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000218	0.00174	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	0.000217	0.00173	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000216	0.00173	CbGpPWpGaD
Mesalazine—CHUK—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	0.000213	0.0017	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000213	0.0017	CbGpPWpGaD
Mesalazine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000312	CcSEcCtD
Mesalazine—CHUK—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000209	0.00167	CbGpPWpGaD
Mesalazine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000311	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000311	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000208	0.00031	CcSEcCtD
Mesalazine—CHUK—Disease—CCNT1—acquired immunodeficiency syndrome	0.000208	0.00166	CbGpPWpGaD
Mesalazine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000208	0.000309	CcSEcCtD
Mesalazine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000309	CcSEcCtD
Mesalazine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000309	CcSEcCtD
Mesalazine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000309	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000309	CcSEcCtD
Mesalazine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000309	CcSEcCtD
Mesalazine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000308	CcSEcCtD
Mesalazine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000206	0.000307	CcSEcCtD
Mesalazine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000206	0.000307	CcSEcCtD
Mesalazine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000306	CcSEcCtD
Mesalazine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.000306	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.000206	0.00164	CbGpPWpGaD
Mesalazine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000306	CcSEcCtD
Mesalazine—CHUK—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000206	0.00164	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	0.000206	0.00164	CbGpPWpGaD
Mesalazine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000305	CcSEcCtD
Mesalazine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000305	CcSEcCtD
Mesalazine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000305	CcSEcCtD
Mesalazine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000205	0.000305	CcSEcCtD
Mesalazine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000304	CcSEcCtD
Mesalazine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000304	CcSEcCtD
Mesalazine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000204	0.000304	CcSEcCtD
Mesalazine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000204	0.000304	CcSEcCtD
Mesalazine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000303	CcSEcCtD
Mesalazine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000303	CcSEcCtD
Mesalazine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000303	CcSEcCtD
Mesalazine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000302	CcSEcCtD
Mesalazine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.000302	CcSEcCtD
Mesalazine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000302	CcSEcCtD
Mesalazine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000301	CcSEcCtD
Mesalazine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000301	CcSEcCtD
Mesalazine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000301	CcSEcCtD
Mesalazine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000301	CcSEcCtD
Mesalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	0.000202	0.00161	CbGpPWpGaD
Mesalazine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.0003	CcSEcCtD
Mesalazine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.0003	CcSEcCtD
Mesalazine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000201	0.000299	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000299	CcSEcCtD
Mesalazine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000298	CcSEcCtD
Mesalazine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000297	CcSEcCtD
Mesalazine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000296	CcSEcCtD
Mesalazine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000296	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000295	CcSEcCtD
Mesalazine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	0.000199	0.00159	CbGpPWpGaD
Mesalazine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000295	CcSEcCtD
Mesalazine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000295	CcSEcCtD
Mesalazine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000294	CcSEcCtD
Mesalazine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000294	CcSEcCtD
Mesalazine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.000294	CcSEcCtD
Mesalazine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000294	CcSEcCtD
Mesalazine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000294	CcSEcCtD
Mesalazine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000293	CcSEcCtD
Mesalazine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000293	CcSEcCtD
Mesalazine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000293	CcSEcCtD
Mesalazine—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000197	0.00157	CbGpPWpGaD
Mesalazine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000293	CcSEcCtD
Mesalazine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	0.000197	0.00157	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000293	CcSEcCtD
Mesalazine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000196	0.000292	CcSEcCtD
Mesalazine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000292	CcSEcCtD
Mesalazine—IKBKB—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000196	0.00157	CbGpPWpGaD
Mesalazine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000291	CcSEcCtD
Mesalazine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000291	CcSEcCtD
Mesalazine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000291	CcSEcCtD
Mesalazine—CHUK—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000195	0.00156	CbGpPWpGaD
Mesalazine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.00029	CcSEcCtD
Mesalazine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00029	CcSEcCtD
Mesalazine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00029	CcSEcCtD
Mesalazine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.00029	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000195	0.00156	CbGpPWpGaD
Mesalazine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.000289	CcSEcCtD
Mesalazine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000289	CcSEcCtD
Mesalazine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000289	CcSEcCtD
Mesalazine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000289	CcSEcCtD
Mesalazine—CHUK—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	0.000194	0.00155	CbGpPWpGaD
Mesalazine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000288	CcSEcCtD
Mesalazine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.000288	CcSEcCtD
Mesalazine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	0.000193	0.00154	CbGpPWpGaD
Mesalazine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000287	CcSEcCtD
Mesalazine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000287	CcSEcCtD
Mesalazine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000287	CcSEcCtD
Mesalazine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000287	CcSEcCtD
Mesalazine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000286	CcSEcCtD
Mesalazine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000286	CcSEcCtD
Mesalazine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000285	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000285	CcSEcCtD
Mesalazine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000285	CcSEcCtD
Mesalazine—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000191	0.00153	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000191	0.00153	CbGpPWpGaD
Mesalazine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000284	CcSEcCtD
Mesalazine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000284	CcSEcCtD
Mesalazine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000284	CcSEcCtD
Mesalazine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000284	CcSEcCtD
Mesalazine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000283	CcSEcCtD
Mesalazine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00019	0.000283	CcSEcCtD
Mesalazine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000283	CcSEcCtD
Mesalazine—IKBKB—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00019	0.00152	CbGpPWpGaD
Mesalazine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00019	0.000282	CcSEcCtD
Mesalazine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000282	CcSEcCtD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000189	0.00151	CbGpPWpGaD
Mesalazine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000281	CcSEcCtD
Mesalazine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.000281	CcSEcCtD
Mesalazine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.00028	CcSEcCtD
Mesalazine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.00028	CcSEcCtD
Mesalazine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00028	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.00028	CcSEcCtD
Mesalazine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000188	0.00028	CcSEcCtD
Mesalazine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.00028	CcSEcCtD
Mesalazine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000188	0.00028	CcSEcCtD
Mesalazine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000279	CcSEcCtD
Mesalazine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000279	CcSEcCtD
Mesalazine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.000279	CcSEcCtD
Mesalazine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000187	0.000278	CcSEcCtD
Mesalazine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000187	0.000278	CcSEcCtD
Mesalazine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000278	CcSEcCtD
Mesalazine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000277	CcSEcCtD
Mesalazine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000277	CcSEcCtD
Mesalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	0.000186	0.00149	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000186	0.00149	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000277	CcSEcCtD
Mesalazine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.000277	CcSEcCtD
Mesalazine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000276	CcSEcCtD
Mesalazine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000275	CcSEcCtD
Mesalazine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000275	CcSEcCtD
Mesalazine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000275	CcSEcCtD
Mesalazine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000275	CcSEcCtD
Mesalazine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000184	0.000274	CcSEcCtD
Mesalazine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000274	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000273	CcSEcCtD
Mesalazine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000183	0.000273	CcSEcCtD
Mesalazine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000273	CcSEcCtD
Mesalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—acquired immunodeficiency syndrome	0.000183	0.00146	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.000183	0.00146	CbGpPWpGaD
Mesalazine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000271	CcSEcCtD
Mesalazine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000271	CcSEcCtD
Mesalazine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00027	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000181	0.00145	CbGpPWpGaD
Mesalazine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00027	CcSEcCtD
Mesalazine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00027	CcSEcCtD
Mesalazine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000269	CcSEcCtD
Mesalazine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000269	CcSEcCtD
Mesalazine—CHUK—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	0.000181	0.00145	CbGpPWpGaD
Mesalazine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000268	CcSEcCtD
Mesalazine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000268	CcSEcCtD
Mesalazine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000267	CcSEcCtD
Mesalazine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000267	CcSEcCtD
Mesalazine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000267	CcSEcCtD
Mesalazine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000267	CcSEcCtD
Mesalazine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000266	CcSEcCtD
Mesalazine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000265	CcSEcCtD
Mesalazine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.000264	CcSEcCtD
Mesalazine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000264	CcSEcCtD
Mesalazine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000264	CcSEcCtD
Mesalazine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.000264	CcSEcCtD
Mesalazine—IKBKB—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000177	0.00142	CbGpPWpGaD
Mesalazine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000177	0.000264	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000263	CcSEcCtD
Mesalazine—IKBKB—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000176	0.00141	CbGpPWpGaD
Mesalazine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000262	CcSEcCtD
Mesalazine—IKBKB—MyD88-independent cascade—IL6—acquired immunodeficiency syndrome	0.000176	0.0014	CbGpPWpGaD
Mesalazine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000261	CcSEcCtD
Mesalazine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000261	CcSEcCtD
Mesalazine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000175	0.00026	CcSEcCtD
Mesalazine—CHUK—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	0.000174	0.00139	CbGpPWpGaD
Mesalazine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000259	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000259	CcSEcCtD
Mesalazine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000258	CcSEcCtD
Mesalazine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000258	CcSEcCtD
Mesalazine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000173	0.000257	CcSEcCtD
Mesalazine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000257	CcSEcCtD
Mesalazine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000257	CcSEcCtD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000173	0.00138	CbGpPWpGaD
Mesalazine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000257	CcSEcCtD
Mesalazine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000256	CcSEcCtD
Mesalazine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000256	CcSEcCtD
Mesalazine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000256	CcSEcCtD
Mesalazine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000256	CcSEcCtD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000172	0.00137	CbGpPWpGaD
Mesalazine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000255	CcSEcCtD
Mesalazine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000254	CcSEcCtD
Mesalazine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000254	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.00017	0.00136	CbGpPWpGaD
Mesalazine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000251	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000251	CcSEcCtD
Mesalazine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.00025	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000249	CcSEcCtD
Mesalazine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000249	CcSEcCtD
Mesalazine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000249	CcSEcCtD
Mesalazine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000247	CcSEcCtD
Mesalazine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000247	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—IL6—acquired immunodeficiency syndrome	0.000166	0.00133	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.000166	0.00133	CbGpPWpGaD
Mesalazine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000247	CcSEcCtD
Mesalazine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000247	CcSEcCtD
Mesalazine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000245	CcSEcCtD
Mesalazine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000165	0.000245	CcSEcCtD
Mesalazine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000245	CcSEcCtD
Mesalazine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000245	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000165	0.00132	CbGpPWpGaD
Mesalazine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000245	CcSEcCtD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	0.000164	0.00131	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	0.000164	0.00131	CbGpPWpGaD
Mesalazine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000243	CcSEcCtD
Mesalazine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000243	CcSEcCtD
Mesalazine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000243	CcSEcCtD
Mesalazine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000242	CcSEcCtD
Mesalazine—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000163	0.0013	CbGpPWpGaD
Mesalazine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.000242	CcSEcCtD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.000162	0.00129	CbGpPWpGaD
Mesalazine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.00024	CcSEcCtD
Mesalazine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000239	CcSEcCtD
Mesalazine—CHUK—Immune System—MBL2—acquired immunodeficiency syndrome	0.000161	0.00128	CbGpPWpGaD
Mesalazine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000239	CcSEcCtD
Mesalazine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000238	CcSEcCtD
Mesalazine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000238	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000238	CcSEcCtD
Mesalazine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000237	CcSEcCtD
Mesalazine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000237	CcSEcCtD
Mesalazine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000237	CcSEcCtD
Mesalazine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000237	CcSEcCtD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000159	0.00127	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000236	CcSEcCtD
Mesalazine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000235	CcSEcCtD
Mesalazine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000235	CcSEcCtD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—acquired immunodeficiency syndrome	0.000158	0.00126	CbGpPWpGaD
Mesalazine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000233	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000156	0.00125	CbGpPWpGaD
Mesalazine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000232	CcSEcCtD
Mesalazine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000229	CcSEcCtD
Mesalazine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000229	CcSEcCtD
Mesalazine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000229	CcSEcCtD
Mesalazine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000228	CcSEcCtD
Mesalazine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000228	CcSEcCtD
Mesalazine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000228	CcSEcCtD
Mesalazine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000227	CcSEcCtD
Mesalazine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000226	CcSEcCtD
Mesalazine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000226	CcSEcCtD
Mesalazine—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000152	0.00121	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000225	CcSEcCtD
Mesalazine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000225	CcSEcCtD
Mesalazine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000224	CcSEcCtD
Mesalazine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000222	CcSEcCtD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—acquired immunodeficiency syndrome	0.000149	0.00119	CbGpPWpGaD
Mesalazine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000221	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000148	0.00118	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000148	0.00118	CbGpPWpGaD
Mesalazine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000219	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000147	0.00117	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.000146	0.00117	CbGpPWpGaD
Mesalazine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000218	CcSEcCtD
Mesalazine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000218	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000146	0.00117	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000146	0.00117	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.000146	0.00117	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000146	0.00116	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000146	0.00116	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MBL2—acquired immunodeficiency syndrome	0.000146	0.00116	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000145	0.00116	CbGpPWpGaD
Mesalazine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000215	CcSEcCtD
Mesalazine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000215	CcSEcCtD
Mesalazine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000214	CcSEcCtD
Mesalazine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000214	CcSEcCtD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000144	0.00115	CbGpPWpGaD
Mesalazine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000213	CcSEcCtD
Mesalazine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000213	CcSEcCtD
Mesalazine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000213	CcSEcCtD
Mesalazine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000212	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000143	0.00114	CbGpPWpGaD
Mesalazine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000212	CcSEcCtD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000142	0.00113	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000141	0.00112	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.00014	0.00112	CbGpPWpGaD
Mesalazine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000207	CcSEcCtD
Mesalazine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000206	CcSEcCtD
Mesalazine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000205	CcSEcCtD
Mesalazine—CHUK—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000138	0.0011	CbGpPWpGaD
Mesalazine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000204	CcSEcCtD
Mesalazine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000204	CcSEcCtD
Mesalazine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000204	CcSEcCtD
Mesalazine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000203	CcSEcCtD
Mesalazine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000203	CcSEcCtD
Mesalazine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000201	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000134	0.00107	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000134	0.00107	CbGpPWpGaD
Mesalazine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000198	CcSEcCtD
Mesalazine—IKBKB—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000133	0.00106	CbGpPWpGaD
Mesalazine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000198	CcSEcCtD
Mesalazine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000197	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000133	0.00106	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.000132	0.00106	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000132	0.00106	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000132	0.00106	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000132	0.00105	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000131	0.00105	CbGpPWpGaD
Mesalazine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000195	CcSEcCtD
Mesalazine—CHUK—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000131	0.00104	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.00013	0.00104	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.00013	0.00104	CbGpPWpGaD
Mesalazine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000193	CcSEcCtD
Mesalazine—CHUK—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000129	0.00103	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000129	0.00103	CbGpPWpGaD
Mesalazine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000191	CcSEcCtD
Mesalazine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000191	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000128	0.00102	CbGpPWpGaD
Mesalazine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000189	CcSEcCtD
Mesalazine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000189	CcSEcCtD
Mesalazine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000188	CcSEcCtD
Mesalazine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000188	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000126	0.00101	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CCR2—acquired immunodeficiency syndrome	0.000126	0.00101	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000124	0.000988	CbGpPWpGaD
Mesalazine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000183	CcSEcCtD
Mesalazine—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000123	0.000985	CbGpPWpGaD
Mesalazine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000182	CcSEcCtD
Mesalazine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000182	CcSEcCtD
Mesalazine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000182	CcSEcCtD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000122	0.000973	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000122	0.000973	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000122	0.000973	CbGpPWpGaD
Mesalazine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000181	CcSEcCtD
Mesalazine—CHUK—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000121	0.000965	CbGpPWpGaD
Mesalazine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000178	CcSEcCtD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.00012	0.000956	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000119	0.000955	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000119	0.000952	CbGpPWpGaD
Mesalazine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000175	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000117	0.000937	CbGpPWpGaD
Mesalazine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000174	CcSEcCtD
Mesalazine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000173	CcSEcCtD
Mesalazine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000172	CcSEcCtD
Mesalazine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000171	CcSEcCtD
Mesalazine—IKBKB—Immune System—CCR2—acquired immunodeficiency syndrome	0.000114	0.000913	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000113	0.000906	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.00011	0.000883	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—acquired immunodeficiency syndrome	0.00011	0.00088	CbGpPWpGaD
Mesalazine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000164	CcSEcCtD
Mesalazine—CHUK—Disease—CXCR4—acquired immunodeficiency syndrome	0.000109	0.000874	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000108	0.000862	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000107	0.000855	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000103	0.000822	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—acquired immunodeficiency syndrome	9.98e-05	0.000798	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	9.98e-05	0.000798	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9e-05	0.00072	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40LG—acquired immunodeficiency syndrome	8.97e-05	0.000717	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—acquired immunodeficiency syndrome	8.87e-05	0.000709	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CSF2—acquired immunodeficiency syndrome	8.87e-05	0.000709	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—acquired immunodeficiency syndrome	8.75e-05	0.000699	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-B—acquired immunodeficiency syndrome	8.53e-05	0.000682	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	8.44e-05	0.000674	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	8.41e-05	0.000672	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	8.4e-05	0.000672	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—acquired immunodeficiency syndrome	8.29e-05	0.000663	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.16e-05	0.000653	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.14e-05	0.000651	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40LG—acquired immunodeficiency syndrome	8.14e-05	0.00065	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—acquired immunodeficiency syndrome	8.04e-05	0.000643	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CSF2—acquired immunodeficiency syndrome	8.04e-05	0.000643	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—acquired immunodeficiency syndrome	7.93e-05	0.000634	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-B—acquired immunodeficiency syndrome	7.74e-05	0.000619	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—acquired immunodeficiency syndrome	7.69e-05	0.000615	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.65e-05	0.000612	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.65e-05	0.000612	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	7.65e-05	0.000612	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	7.62e-05	0.000609	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—acquired immunodeficiency syndrome	7.52e-05	0.000601	CbGpPWpGaD
Mesalazine—CHUK—Disease—CCR5—acquired immunodeficiency syndrome	7.49e-05	0.000599	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.49e-05	0.000599	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.38e-05	0.00059	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—acquired immunodeficiency syndrome	7.07e-05	0.000565	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.94e-05	0.000555	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.94e-05	0.000555	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	6.47e-05	0.000518	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.95e-05	0.000475	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.82e-05	0.000465	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.74e-05	0.000459	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—acquired immunodeficiency syndrome	5.71e-05	0.000456	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.28e-05	0.000422	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—acquired immunodeficiency syndrome	5.28e-05	0.000422	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.25e-05	0.000419	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.2e-05	0.000416	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—acquired immunodeficiency syndrome	5.1e-05	0.000407	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—acquired immunodeficiency syndrome	4.78e-05	0.000382	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—acquired immunodeficiency syndrome	4.76e-05	0.000381	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.76e-05	0.00038	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—acquired immunodeficiency syndrome	4.73e-05	0.000378	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—acquired immunodeficiency syndrome	4.7e-05	0.000376	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—acquired immunodeficiency syndrome	4.69e-05	0.000375	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—acquired immunodeficiency syndrome	4.62e-05	0.000369	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	4.44e-05	0.000355	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—acquired immunodeficiency syndrome	4.29e-05	0.000343	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—acquired immunodeficiency syndrome	4.25e-05	0.00034	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	3.34e-05	0.000267	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.03e-05	0.000242	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	2.79e-05	0.000223	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—acquired immunodeficiency syndrome	2.76e-05	0.00022	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.75e-05	0.00022	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	2.65e-05	0.000212	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—acquired immunodeficiency syndrome	2.54e-05	0.000203	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—acquired immunodeficiency syndrome	2.5e-05	0.0002	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.78e-05	0.000142	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.62e-05	0.000129	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	1.51e-05	0.00012	CbGpPWpGaD
